Streetbeat News

Stock Prices

PVH

Over the past 15 years, PVH (NYSE:PVH) has produced an average annual return of 16.13%, outperforming the market by 1.89% annually. A $100 investment in PVH 15 years ago would now be worth $920.32. PVH's current market capitalization stands at $8.17 billion.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 2:30 pm

IPWR

Ideal Power (NASDAQ:IPWR) reported Q4 earnings, beating estimates with an EPS of $-0.39 against an expected $-0.42. Revenue increased by $44 thousand year-over-year. Despite missing EPS estimates last quarter, the share price increased by 11.0% the following day.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 2:30 pm

BBWI

Bath & Body Works, Inc. (NYSE:BBWI) shares fell after reporting Q4 earnings and a modest outlook for Q1 and FY24. Despite beating Q4 earnings and revenue estimates, the company's forecast for net sales and EPS for the full year and Q1 2024 is below consensus estimates. BBWI also announced a new $500 million share repurchase program.

Portfolio Pulse from Nabaparna Bhattacharya

February 29, 2024 | 2:27 pm

IPWR

Ideal Power (NASDAQ:IPWR) reported Q4 2023 earnings with a smaller loss per share of $(0.39) than the estimated $(0.42), beating expectations by 7.14%. Sales for the quarter were $61.48K, marking a significant increase of 270.20% from $16.61K in the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 2:24 pm

MULN

Mullen Technologies has progressed its solid-state battery pack from lab testing to on-road vehicle testing in its Class 1 EV Cargo Van, achieving an 86% increase in vehicle range from 110 miles to 205 miles, surpassing the previously projected 73% increase.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 2:23 pm

GSK

GSK Plc (NYSE:GSK) has confidentially settled another lawsuit in California alleging its heartburn drug Zantac caused cancer. This is the second settlement within a month, with previous cases also resolved confidentially. GSK does not admit liability in these settlements. The settlements resolve the final three breast cancer bellwether cases in California, exempting GSK from further pre-trial hearings. Zantac was a top-selling medication but was pulled from the market in 2020 due to carcinogenic concerns. GSK's stock rose 1.02 to $42.77 in premarket trading.

Portfolio Pulse from Vandana Singh

February 29, 2024 | 2:21 pm

CRON

Cronos Group Inc. (NASDAQ:CRON) reported its Q4 and full-year 2023 results, showing a reduced net loss and increased revenue. The company highlighted its global expansion, including entering Germany and Australia, and launching the Lord Jones brand in Canada. Q4 net loss improved to $(45) million from $(78.9) million in the same quarter of 2022, and full-year net loss improved to $(74.6) million from $(168.73) million in 2022. Shares traded 0.51% lower at $2.25 in Thursday's pre-market session.

Portfolio Pulse from Nina Zdinjak

February 29, 2024 | 2:21 pm

IWM

UUP

Tech stocks are poised for gains following January inflation data that met expectations, potentially easing the path for Fed rate cuts. Nasdaq 100 futures rose 0.6%, while S&P 500 futures increased by 0.4%. The Russell 2000 index, as tracked by the iShares Russell 2000 ETF, surged 1.6%. The U.S. Dollar Index, monitored through the Invesco DB USD Index Bullish Fund ETF, declined by 0.2%. Notable premarket movers include Netflix, Broadcom, NVIDIA, AMD, and Tesla among top gainers, with PepsiCo, McDonald's, and Boeing leading the declines.

Portfolio Pulse from Piero Cingari

February 29, 2024 | 2:20 pm

HSY

MDLZ

NSRGF

XLP

Cocoa prices have seen a significant fluctuation, hitting a record high before slumping 13% in three days, yet the market remains in short supply. This situation has impacted companies like Hershey Co, which expects flat earnings for 2024 due to higher raw materials costs. Similarly, Mondelez International Inc. and Nestle SA have seen their shares fall this month. The Consumer Staples Select Sector SPDR ETF has gained 12.6% since mid-October, indicating some resilience in the consumer staples sector despite the cocoa crisis.

Portfolio Pulse from Neil Dennis

February 29, 2024 | 2:20 pm

GPOR

Truist Securities analyst Neal Dingmann has maintained a Buy rating on Gulfport Energy (NYSE:GPOR) and increased the price target from $170 to $184. This adjustment reflects a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 2:14 pm